A randomised comparison of the Ambu® AuraGain and the LMA® supreme in infants and children

N. Jagannathan*, J. Hajduk, L. Sohn, A. Huang, A. Sawardekar, E. R. Gebhardt, K. Johnson, G. S. De Oliveira

*Corresponding author for this work

Research output: Contribution to journalArticle

18 Scopus citations


We conducted a randomised trial in 100 children in order to compare the clinical performance of the Ambu® AuraGain and the LMA® Supreme for airway maintenance during mechanical ventilation. The primary outcomes were initial and 10-min airway leak pressures. Ease, time and success rates for device and gastric tube insertion, fibreoptic grades of view, airway quality during anaesthetic maintenance, and complications were also assessed. There were no differences in the initial and ten min airway leak pressures between the Ambu AuraGain and LMA Supreme, median (IQR [range]) initial: 19 (16-22 [10-34]) vs 18 (14-24 [8-40]) cmH2O, p = 0.4; and ten min: 22 (18-26 [11-40]) vs 20 (16-26 [12-40]) cmH2O, p = 0.08, respectively. Ease, time and success rates for device placement, gastric tube insertion and complications were also not significantly different. Children receiving the LMA Supreme required more airway manouevers (7 vs 1 patient, p = 0.06) to maintain a patent airway. Our results suggest that the Ambu AuraGain may be a useful alternative to the LMA Supreme, as demonstrated by comparable overall clinical performance in children.

Original languageEnglish (US)
Pages (from-to)205-212
Number of pages8
Issue number2
StatePublished - Feb 1 2016

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'A randomised comparison of the Ambu<sup>®</sup> AuraGain<sup>™</sup> and the LMA<sup>®</sup> supreme in infants and children'. Together they form a unique fingerprint.

  • Cite this